ConcertAI names D'Ambrosio chief revenue officer

2019 12 09 17 23 6730 Artificial Intelligence Ai Suit 400

ConcertAI recently appointed Claudio D'Ambrosio, PhD, as the company’s first chief revenue officer. D'Ambrosio has been with ConcertAI since 2020 as the head of the firm's biopharma partnerships and real-world evidence (RWE) software divisions.

ConcertAI develops artificial intelligence (AI) software-as-a-service (SaaS) technology and RWE software for life sciences and healthcare.

In this new role, D'Ambrosio will lead all biopharma partnering programs and multi-year initiatives in clinical development and post-approval studies.

Before his arrival at ConcertAI, D'Ambrosio served as the head of life sciences for Varian Medical Systems' oncology software solutions. He was also chief commercial officer for Noona.

Page 1 of 360
Next Page